Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice

Phytomedicine

Volumn 16, Issue 5, 2009, Pages 437-443

  Kawano, Atsutoshi ^a   Nakamura, Hiromichi ^b   Hata, Shu ichi ^b   Minakawa, Miki ^a   Miura, Yutaka ^a   Yagasaki, Kazumi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b Tama Biochemical Co   (Japan)

Author keywords

Aspalathin; Aspalathus linearis; db db mice; Hypoglycemic effect; Myotubes; Pancreatic cell; Type 2 diabetes

Indexed keywords

ASPALATHIN; ASPALATHUS LINEARIS EXTRACT; GLUCOSE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPALATHUS; CONTROLLED STUDY; DBA MOUSE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MOUSE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; TEA; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ASPALATHUS; CELLS, CULTURED; CHALCONES; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MUSCLE FIBERS, SKELETAL; PHYTOTHERAPY; PLANT EXTRACTS; RATS; TEA;

ASPALATHUS LINEARIS; MUS;

EID: 64449086955     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.11.009     Document Type: Article

References (21)

1. Banskota A.H., Nguyen N.T., Tezuka Y., Nobukawa T., and Kadota S. Hypoglycemic effects of the wood of Taxus yunnanensis on streptozotocin-induced diabetic rats and its active components. Phytomedicine 13 (2006) 109-114
2. Blair A.S., Hajduch E., Litherland G.J., and Hundal H.S. Regulation of glucose transport and glycogen synthersis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 274 (1999) 36293-36299
3. Bramati L., Minoggio M., Gardana C., Simonetti P., Mauri P., and Pietta P.G. Quantitative characterization of flavonoid compounds in Rooibos tea (Aspalathus linearis) by LC-UV/DAD. J. Agric. Food Chem. 50 (2002) 5513-5519
4. Bramati L., Aquilano F., and Pietta P.G. Unfermented rooibos tea: quantitative characterization of flavonoids by HPLC-UV and determination of the total antioxidant activity. J. Agric. Food Chem. 51 (2003) 7472-7474
5. Chick W.L., Warren S., Chute R.N.M., Like A.A., Lauris V., and Kitchen K.C. A transplantable insulinoma in the rat. Proc. Natl. Acad. Sci. USA 74 (1977) 628
6. 12 myotubes. Biochem. Biophys. Res. Commun. 312 (2003) 1111-1117
7. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 (1998) 229-234
8. Houstis N., Rosen D.E., and Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
9. Ishida H., Takizawa M., Ozawa S., Nakamichi Y., Yamaguchi S., Katsuta H., Tanaka T., Maruyama M., Katahira H., Yoshimoto K., Itagaki E., and Nagamatsu S. Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: possible protection of β-cells from oxidative stress. Metabolism 53 (2004) 488-494
10. Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., Hanafusa T., Matsuzawa Y., Yamasaki Y., and Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48 (1999) 2398-2406
11. Lenzen S., Drinkgern J., and Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20 (1996) 463-466
12. McKay D.L., and Blumberg J.B. A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia). Phytother. Res. 21 (2007) 1-16
13. Moller M.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414 (2001) 821-827
14. Morton J.F. Rooibos tea, Aspalathus linearis, a caffeinless, low-tannin beverage. Econ. Bot. 37 (1983) 164-173
15. Nishitani S., Matsumura T., Fujitani S., Sonaka I., Miura Y., and Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem. Biophys. Res. Commun. 299 (2002) 693-696
16. Nomura E., Kashiwada A., Hosoda A., Nakamura K., Morishita H., Tsuno T., and Taniguchi H. Synthesis of amide compounds of ferulic acid, and their stimulatory effects on insulin secretion in vitro. Bioorg. Med. Chem. 11 (2003) 3807-3813
17. Rabe C., Steenkamp J.A., Joubert E., Burger J.F.W., and Ferreira D. Phenolic metabolites from rooibos tea (Aspalathus linearis). Phytochemistry 35 (1994) 1559-1565
18. Tiedge M., Lortz S., Drinkgern J., and Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46 (1997) 1733-1742
19. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
20. Yaffe D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. USA 61 (1968) 477-483
21. Yagasaki K., Morisaki N., Kitahara Y., Miura A., and Funabiki R. Involvement of protein kinase C activation in l-leucine-induced stimulation of protein synthesis in L6 myotubes. Cytotechnology 43 (2003) 97-103